• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Retinol palmitate
Date Designated: 08/08/2016
Orphan Designation: Prevention of bronchopulmonary dysplasia.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Orphanix GmbH
41 Peter-Rosegger-Straße
Ried im Innkreis, Oberösterreich

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.